Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carlos Alban Insider Profile
11 Followers
Carlos Alban, Vice Chairman at AbbVie, holds 14.71K shares in Springworks Therapeutics (Ticker: SWTX), holds 155.34K shares in AbbVie (Ticker: ABBV), holds 136.14K shares in Abbott Labs (Ticker: ABT).
Carlos Alban has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Carlos Alban holds in companies
Most Profitable Insider Trade
The most profitable trade made by Carlos Alban
Carlos Alban's Trading History
AbbVie
Nov 18, 2020
Vice Chairman
Uninformative Sell
11.58M
$26.08M
Springworks Therapeutics
May 25, 2023
Director
Uninformative Buy
―
$630.74K
Abbott Labs
Dec 04, 2012
SVP
Uninformative Buy
―
$14.58M
List of latest transactions for each holding click on a transaction to see Carlos Alban's performance on stock
You May Also Like
Carlos Alban insider profile FAQ
What is the percentage of profitable transactions made by Carlos Alban?
The percentage of profitable transactions made by Carlos Alban is ―.
What is the average return per transaction made by Carlos Alban?
The average return per transaction made by Carlos Alban is ―.
What stocks does Carlos Alban hold?
Carlos Alban holds: ABBV, SWTX, ABT stocks.
What was Carlos Alban’s latest transaction?
Carlos Alban latest transaction was an Uninformative Buy of ―.
What was Carlos Alban's most profitable transaction?
Carlos Alban’s most profitable transaction was an Informative Buy of ABBV stock on June 15, 2017. The return on the trade was 45.80%.
What is Carlos Alban's role in AbbVie?
Carlos Alban's role in AbbVie is Vice Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.